129 related articles for article (PubMed ID: 31624079)
1. Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2).
Hörmann S; Gai Z; Kullak-Ublick GA; Visentin M
J Pharmacol Exp Ther; 2020 Jan; 372(1):46-53. PubMed ID: 31624079
[TBL] [Abstract][Full Text] [Related]
2. The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2).
Sutter ML; Console L; Fahner AF; Samodelov SL; Gai Z; Ciarimboli G; Indiveri C; Kullak-Ublick GA; Visentin M
Biochem Pharmacol; 2021 Dec; 194():114840. PubMed ID: 34774844
[TBL] [Abstract][Full Text] [Related]
3. Effect of 7-ketocholesterol incorporation on substrate binding affinity and turnover rate of the organic cation transporter 2 (OCT2).
Xiu F; Console L; Indiveri C; Su S; Wang T; Visentin M
Biochem Pharmacol; 2024 Feb; 220():116017. PubMed ID: 38176620
[TBL] [Abstract][Full Text] [Related]
4. Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.
Sandoval PJ; Morales M; Secomb TW; Wright SH
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F720-F734. PubMed ID: 31313952
[TBL] [Abstract][Full Text] [Related]
5. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.
Belzer M; Morales M; Jagadish B; Mash EA; Wright SH
J Pharmacol Exp Ther; 2013 Aug; 346(2):300-10. PubMed ID: 23709117
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2).
Zhang L; Gui T; Console L; Scalise M; Indiveri C; Hausler S; Kullak-Ublick GA; Gai Z; Visentin M
J Biol Chem; 2021; 296():100204. PubMed ID: 33334877
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of a Biguanide Scaffold Enhances Drug Uptake by Organic Cation Transporters 1 and 2.
Obianom ON; Coutinho AL; Yang W; Yang H; Xue F; Shu Y
Mol Pharm; 2017 Aug; 14(8):2726-2739. PubMed ID: 28699756
[TBL] [Abstract][Full Text] [Related]
8. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O
PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.
Sandoval PJ; Zorn KM; Clark AM; Ekins S; Wright SH
Mol Pharmacol; 2018 Sep; 94(3):1057-1068. PubMed ID: 29884691
[TBL] [Abstract][Full Text] [Related]
10. Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors.
Visentin M; Torozi A; Gai Z; Häusler S; Li C; Hiller C; Schraml PH; Moch H; Kullak-Ublick GA
Drug Metab Dispos; 2018 Aug; 46(8):1129-1136. PubMed ID: 29794161
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).
Zolk O; Solbach TF; König J; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):337-48. PubMed ID: 19002438
[TBL] [Abstract][Full Text] [Related]
12. Activation of liver X receptor inhibits OCT2-mediated organic cation transport in renal proximal tubular cells.
Wongwan T; Kittayaruksakul S; Asavapanumas N; Chatsudthipong V; Soodvilai S
Pflugers Arch; 2017 Nov; 469(11):1471-1481. PubMed ID: 28741179
[TBL] [Abstract][Full Text] [Related]
13. The conditional stimulation of rat organic cation transporter 2, but not its human ortholog, by mesoridazine: the possibility of the involvement of the high-affinity binding site of the transporter in the stimulation.
Hyung S; Pyeon W; Park JE; Song YK; Chung SJ
J Pharm Pharmacol; 2017 Nov; 69(11):1513-1523. PubMed ID: 28809437
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
Choi MK; Song IS
Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Effect of Crizotinib on Creatinine Uptake by Renal Secretory Transporter OCT2.
Arakawa H; Omote S; Tamai I
J Pharm Sci; 2017 Sep; 106(9):2899-2903. PubMed ID: 28336299
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ligand-induced thermal stability of the human organic cation transporter 2 (OCT2).
Maane M; Xiu F; Bellstedt P; Kullak-Ublick GA; Visentin M
Front Pharmacol; 2023; 14():1154213. PubMed ID: 37007010
[No Abstract] [Full Text] [Related]
17. Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.
Harper JN; Wright SH
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F56-67. PubMed ID: 23034939
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug interaction between crizotinib and entecavir via renal secretory transporter OCT2.
Shu W; Ma L; Hu X; Zhang M; Chen W; Ma W; Huang J; Li J
Eur J Pharm Sci; 2020 Jan; 142():105153. PubMed ID: 31740393
[TBL] [Abstract][Full Text] [Related]
19. Organic cation transporter mRNA and function in the rat superior cervical ganglion.
Kristufek D; Rudorfer W; Pifl C; Huck S
J Physiol; 2002 Aug; 543(Pt 1):117-34. PubMed ID: 12181285
[TBL] [Abstract][Full Text] [Related]
20. Substrate-Dependent
Lefèvre CR; Le Vée M; Gaubert S; Jouan E; Bruyere A; Moreau C; Fardel O
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
